title: Increased fibronectin-receptor expression in colon carcinoma-derived HT 29 cells decreases tumorigenicity in nude mice.
abstract: OBJECTIVE
  Following malignant transformation, epithelial cells of colorectal carcinomas, unlike normal colonic epithelial cells, no longer express the alpha 5 beta 1 fibronectin receptor. We hypothesized that the loss of alpha 5 beta 1 expression might facilitate the tumorigenicity of transformed colonic cells.
  
  
  METHODS
  To examine this hypothesis, we established subclones of the human colon adenocarcinoma cell line HT 29, which differ in their fibronectin receptor expression and tested their tumorigenicity in nude mice.
  
  
  RESULTS
  Our data indicate that the capacity to form tumors in nude mice after subcutaneous injection was significantly lower for alpha 5-positive than for alpha 5-negative cell clones. In addition, tumors from clones expressing no detectable levels of alpha 5 beta 1 grew rapidly, whereas tumors expressing elevated levels of fibronectin receptor grew slowly. Despite similar rates of adhesion to fibronectin for alpha 5-positive and alpha 5-negative cell clones in vitro, deposition of fibronectin in tumor-surrounding stroma was increased in tumors derived from alpha 5-positive cells.
  
  
  CONCLUSIONS
  Our results indicate that an increase of the alpha 5 beta 1-mediated interaction of malignant cells with the extracellular matrix may be responsible for decreased tumorigenicity of malignant transformed cells in colorectal carcinomas.
authors.affiliation: Department of Gastroenterology, Klinikum Steglitz, Free University of Berlin, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Stallmach
authors.forename: B
authors.initials: B
authors.lastname: von Lampe
authors.forename: H D
authors.initials: HD
authors.lastname: Orzechowski
authors.forename: H
authors.initials: H
authors.lastname: Matthes
authors.forename: E O
authors.initials: EO
authors.lastname: Riecken
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D000818:Animals; D015197:Carcinogenicity Tests; D002448:Cell Adhesion; D003110:Colonic Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D005109:Extracellular Matrix / Q000378:metabolism; D005260:Female; D005353:Fibronectins / Q000502:physiology; D006801:Humans; D016023:Integrins / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D017469:Receptors, Fibronectin / Q000378:metabolism*; D014407:Tumor Cells, Cultured / Q000637:transplantation
chemical_list: D005353:Fibronectins; D016023:Integrins; D017469:Receptors, Fibronectin